- Home
- DERM vs CAAS Comparison
DERM vs CAAS Comparison
Compare DERM & CAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- CAAS
- Stock Information
- Founded
- DERM 2014
- CAAS N/A
- Country
- DERM United States
- CAAS China
- Employees
- DERM N/A
- CAAS N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- CAAS Auto Parts:O.E.M.
- Sector
- DERM Health Care
- CAAS Consumer Discretionary
- Exchange
- DERM Nasdaq
- CAAS Nasdaq
- Market Cap
- DERM 116.8M
- CAAS 111.1M
- IPO Year
- DERM 2021
- CAAS N/A
- Fundamental
- Price
- DERM $4.68
- CAAS $4.13
- Analyst Decision
- DERM Strong Buy
- CAAS
- Analyst Count
- DERM 3
- CAAS 0
- Target Price
- DERM $9.50
- CAAS N/A
- AVG Volume (30 Days)
- DERM 109.1K
- CAAS 43.8K
- Earning Date
- DERM 11-12-2024
- CAAS 11-13-2024
- Dividend Yield
- DERM N/A
- CAAS N/A
- EPS Growth
- DERM N/A
- CAAS 2.02
- EPS
- DERM N/A
- CAAS 1.05
- Revenue
- DERM $57,771,000.00
- CAAS $621,377,000.00
- Revenue This Year
- DERM N/A
- CAAS $4.97
- Revenue Next Year
- DERM $36.49
- CAAS N/A
- P/E Ratio
- DERM N/A
- CAAS $3.93
- Revenue Growth
- DERM N/A
- CAAS 13.81
- 52 Week Low
- DERM $2.85
- CAAS $3.05
- 52 Week High
- DERM $8.10
- CAAS $4.97
- Technical
- Relative Strength Index (RSI)
- DERM 35.33
- CAAS 43.95
- Support Level
- DERM $4.88
- CAAS $3.76
- Resistance Level
- DERM $5.19
- CAAS $4.52
- Average True Range (ATR)
- DERM 0.29
- CAAS 0.21
- MACD
- DERM -0.07
- CAAS -0.05
- Stochastic Oscillator
- DERM 10.94
- CAAS 45.12
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About CAAS China Automotive Systems Inc.
China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, more than 310 models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.